ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Makes ER-Negative Breast Cancer Easier To Find

October 31, 2008

In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69

August 12, 1988

Breast Cancer Low Fat Investigators to Seek R01 Funds for New Compliance, Biochemical Studies

April 25, 1986

CAB Reluctantly Approves Use Of Contract To Support Cancer Journals

February 15, 1985

NCI Will Encourage More Activity In Environment Carcinogenesis

June 21, 1974

Bass & Howes Bought By DDB Seattle

March 22, 2002